Grace Therapeutics, Inc. (ACST)
2.12
+0.02
(+0.95%)
USD |
NASDAQ |
Sep 08, 16:00
Grace Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.0004 |
| September 30, 2023 | 0.0007 |
| June 30, 2023 | 0.0012 |
| March 31, 2023 | 0.0071 |
| December 31, 2022 | 0.0052 |
| September 30, 2022 | 0.0052 |
| June 30, 2022 | 0.0078 |
| March 31, 2022 | 0.0027 |
| December 31, 2021 | 0.0002 |
| September 30, 2021 | 0.0004 |
| June 30, 2021 | 0.0012 |
| March 31, 2021 | 0.0015 |
| December 31, 2020 | 0.0041 |
| September 30, 2020 | 0.0134 |
| June 30, 2020 | 0.0122 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.3168 |
| September 30, 2019 | -1.149 |
| June 30, 2019 | 0.5234 |
| March 31, 2019 | 0.1301 |
| December 31, 2018 | 0.0577 |
| September 30, 2018 | -0.1156 |
| June 30, 2018 | 0.2206 |
| March 31, 2018 | 0.196 |
| December 31, 2017 | 0.1025 |
| September 30, 2017 | 0.1019 |
| June 30, 2017 | 0.0768 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | 0.00 |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.00 |
| November 30, 2014 | 0.00 |
| August 31, 2014 | 0.0021 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.00 |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Abeona Therapeutics, Inc. | 0.1552 |
| America Great Health | -0.6512 |
| Acumen Pharmaceuticals, Inc. | 0.5526 |
| Aardvark Therapeutics, Inc. | 0.0091 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 50.07M |
| Total Liabilities (Quarterly) | 1.862M |
| Shareholders Equity (Quarterly) | 48.21M |
| Current Ratio | 11.47 |